Key Takeaways
- PLTR shares declined between 3.5% and 4.6% on Tuesday, retreating from the recent 2026 closing peak of $186.38
- Cathie Wood’s ARK Invest offloaded roughly 139,456 shares valued at $26 million on August 31
- Second-quarter results exceeded expectations, featuring 92.8% revenue growth year over year and EPS of $0.41 versus $0.34 consensus
- Trading at approximately 154 times earnings, the elevated valuation remains a concern for market observers
- A September 1 U.S. Army TITAN production contract award failed to halt the downward momentum
Shares of Palantir (PLTR) experienced a decline ranging from 3.5% to 4.6% during Tuesday’s session, touching intraday lows of $179.75 before closing around $179.92. This represents a meaningful pullback from the 2026 session high of $186.38 recorded just days prior.
Palantir Technologies Inc., PLTR
The data analytics company has experienced remarkable volatility recently. Following a stellar second-quarter earnings release in early August, PLTR climbed approximately 48% from its pre-earnings levels. The company reported revenue of $1.94 billion, representing a 92.8% year-over-year increase that handily surpassed analyst projections of $1.81 billion. Earnings per share reached $0.41, exceeding the Street consensus of $0.34 by $0.07.
The 52-week peak stands at $207.52, indicating that despite recent strength, the shares remain below their historical highs.
Tuesday’s trading activity came in 47% lighter than typical volume levels, indicating the selloff was measured rather than driven by widespread panic.
Cathie Wood’s ARK Continues Reduction Strategy
The most identifiable headwind facing PLTR recently is ARK Invest’s ongoing position reduction. On August 31, Cathie Wood’s investment firm divested approximately 139,456 Palantir shares valued at roughly $26 million. This transaction represents the latest in a series of reductions executed throughout August, with proceeds being reallocated to positions in Block and Rocket Lab.
ARK has systematically reduced exposure during each rally phase following the earnings announcement. Market participants have taken notice of this selling pattern.
Corporate insiders have similarly been active sellers. During the trailing 90-day period, company insiders offloaded 720,166 shares totaling approximately $116.8 million. Notable transactions include Shyam Sankar’s sale of 35,000 shares at $155.70 on August 6, and Jeffrey Buckley’s disposition of 1,250 shares at $174.29 on August 21. Both sales were conducted through pre-established 10b5-1 trading arrangements.
Premium Valuation Remains Front and Center
Trading at approximately 154 to 155 times trailing earnings, the valuation metric continues to dominate discussions. Analysts maintain a consensus price objective of $192.19 alongside a “Moderate Buy” recommendation. Price targets vary across Wall Street, with Needham establishing a $215 target, Northland Securities projecting $200, and Phillip Securities recently elevating their forecast to $202.
However, the premium earnings multiple leaves the stock vulnerable to sharp corrections when investor sentiment shifts.
On a positive note, Palantir’s customer count expanded 24% to reach 1,049. Commercial segment revenue now trails government revenue by merely $45 million and could potentially surpass it within the next quarter.
Army TITAN Contract Milestone
Palantir received encouraging news on September 1 with the announcement of a U.S. Army TITAN ground station production contract, representing advancement from the prototype stage to full production. While this development wasn’t sufficient to counteract selling pressure, it strengthens the company’s already robust government project pipeline.
Pentagon-related demand is nearing a $1 billion annual run rate. Baird maintained its Outperform rating, while Zacks recently elevated PLTR to a “Strong Buy” recommendation.
The broader equity market wasn’t responsible for Tuesday’s decline. Both the S&P 500 and Nasdaq posted modest gains, making PLTR’s weakness distinctly company-specific.
Technical indicators show the stock’s 50-day moving average at $145.10 and its 200-day moving average at $142.38, both significantly beneath current trading levels.


